0001144204-18-007688.txt : 20180213
0001144204-18-007688.hdr.sgml : 20180213
20180213131024
ACCESSION NUMBER: 0001144204-18-007688
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20180213
DATE AS OF CHANGE: 20180213
EFFECTIVENESS DATE: 20180213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
IRS NUMBER: 464028844
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16497
FILM NUMBER: 18601605
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001594912
XXXXXXXX
12-31-2017
12-31-2017
false
Foresite Capital Management II, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-16497
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
02-13-2018
0
11
286236
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
10387
244756
SH
SOLE
244756
0
0
Aerie Pharmaceuticals, Inc.
COM
00771V108
99945
1672714
SH
SOLE
1672714
0
0
Aimmune Therapeutics, Inc.
COM
00900T107
117248
3100146
SH
SOLE
3100146
0
0
Alder BioPharmaceuticals, Inc.
COM
014339105
11952
1043832
SH
SOLE
1043832
0
0
Alder BioPharmaceuticals, Inc.
COM
014339905
40
24000
SH
Call
SOLE
24000
0
0
Denali Therapeutics Inc.
COM
24823R105
3910
250000
SH
SOLE
250000
0
0
Epizyme, Inc.
COM
29428V104
19554
1558108
SH
SOLE
1558108
0
0
Insmed Incorporated
COM
457669307
16171
518645
SH
SOLE
518645
0
0
Juno Therapeutics, Inc.
COM
48205A109
3885
85000
SH
SOLE
85000
0
0
Loxo Oncology, Inc.
COM
548862101
1002
11900
SH
SOLE
11900
0
0
uniQure N.V.
SHS
N90064101
2142
109350
SH
SOLE
109350
0
0